Navigation Links
Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
Date:11/6/2007

day multi-

dose study in healthy volunteers for the company's non-nucleoside

reverse transcriptase inhibitor (NNRTI) candidate IDX899 for the

treatment of HIV. The full preclinical data and these first human data

were submitted for presentation at the Conference on Retroviruses and

Opportunistic Infections (CROI), which will be held in February 2008.

"While this has been a challenging time in the evolution of Idenix, we continue to be optimistic about the company's future," said Jean-Pierre Sommadossi, Ph.D., chairman and chief executive officer of Idenix. "The restructuring will allow us to devote our resources to the discovery and development of antiviral drugs for the treatment of HCV and HIV. We have had active HCV and HIV discovery programs underway for the past 18 months and are very excited about the candidates in our pipeline."

2007 Financial Guidance

Idenix continues to expect to end 2007 with between $100 million and $110 million of cash, cash equivalents and marketable securities.

Conference Call and Webcast Information

Idenix will hold a conference call today at 4:30 p.m. ET. To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475 International and enter passcode 21545602. To listen to a live webcast of the call, go to "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 10 minutes before the call to ensure a timely connection. A replay of the conference call and webcast will be available until November 20, 2007. To access the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter the passcode 21545602.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious dis
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... June 03, 2015 These are challenging ... The ever growing number of digital-first business are rewriting ... is now a serious need for traditional businesses to ... they operate and deliver their services. On top ... between incumbents and technology start-ups, to bring new innovation ...
(Date:6/3/2015)... “ Scanalytics ” was featured on NewsWatch ... the latest and coolest technology products available to consumers. ... NewsWatch, conducted the review and shared with viewers how ... retail stores. , Tracking statistics in business is invaluable ... to retail this goes a step beyond revenue statistics ...
(Date:6/3/2015)... 2015 Foot and Ankle Specialists ... Friske ( Clarksville Division ) was recently presented ... of Advanced Wound Care (SAWC) and the American Podiatric ... Davis. The Conference was held on April 29-May ... in San Antonio, TX. , Dr. Casey Friske ...
(Date:6/3/2015)... Netherlands (PRWEB) June 03, 2015 Unfortunately, a ... when it comes to providing comfort to the users throughout ... designer brand or one from the local market, the makers ... exterior and, in the process, often overlook comfort and health. ... kind of shoe, the creative heads at Vay Technologies have ...
(Date:6/2/2015)... BALTIMORE, Md. – Ellarea Maria Cole Stansbury ... being diagnosed with lupus. In spite of genetic and ... enhance health, lupus and other autoimmune related diseases are ... ,” she offers a holistic approach to live with ... overview of some autoimmune diseases—especially lupus —including symptoms, ...
Breaking Medicine News(10 mins):Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 3Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3
... to halt the uncontrolled growth of cancer cells, scientists at ... called PARP inhibitors, may block the ability of pre-leukemic cells ... cells to self-destruct. Results of their experiments, expected to ... Society of Hematology in San Diego, Dec. 12, have already ...
... comes to receiving dental care, New Jersey has its share ... 2009, more than one-fifth of the state,s children between 3 ... While an improvement over 2001, when almost one-third of the ... children and those without health insurance were still likely to ...
... most common and lethal of all human brain tumors ... involves surgery followed by both radiation therapy and chemotherapy ... effects of temozolomide. A team of researchers led by ... now determined that the protein APNG can contribute to ...
... DAEGU, SOUTH KOREAParticipation in horticultural activities can improve ... and rejuvenate the mind and body. Many studies ... relation to physical and psychological rehabilitation, but few ... activities on mentally challenged people,s autonomic nervous system ...
... HealthDay Reporter , MONDAY, Dec. 12 (HealthDay News) -- ... Friday said that the Ortho Evra birth control patch carries a ... but should not be taken off drug store shelves. The ... review of the data, voted 19 to 5 that the benefits ...
... how malaria manipulates the immune system to allow the parasite ... pathway, the research team was able to cure mice of ... 11 in the Advance Online Publication of the journal ... approach for treating malaria that does not rely on vaccination ...
Cached Medicine News:Health News:'PARP' drug sabotages DNA repair in pre-leukemic cells 2Health News:'PARP' drug sabotages DNA repair in pre-leukemic cells 3Health News:Rutgers Study: When it comes to use of dental services, not all NJ youngsters are equal 2Health News:Rutgers Study: When it comes to use of dental services, not all NJ youngsters are equal 3Health News:Planting improves heart rate, stress levels of mentally challenged adults 2Health News:Planting improves heart rate, stress levels of mentally challenged adults 3Health News:FDA Panel Cites Clot Risk From Contraceptive Patch 2Health News:Researchers use new finding to clear bloodstream malaria infection in mice 2Health News:Researchers use new finding to clear bloodstream malaria infection in mice 3
(Date:6/3/2015)...  VA North Texas Health Care System announces ... a technology-based, scientifically advanced weight loss therapy.  ... the Maestro® Rechargeable System that intermittently blocks intra-abdominal ... food intake and processing between the brain and ... to meet the needs of a patient,s changing ...
(Date:6/3/2015)... , June 3, 2015 aTyr Pharma, Inc. (NASDAQ: ... and development of Physiocrine-based therapeutics to address rare diseases, today ... William Blair Growth Stock Conference to be held at the ... June 9-11, 2015. John Mendlein , aTyr,s ... on the Company at 9:20 a.m. CT on Wednesday, June ...
(Date:6/3/2015)... 2015  Armetheon, Inc., a specialty pharmaceutical company ... today announced that Sanjay Kakkar , MD, ... effective immediately. Dr. Kakkar brings more than 20 ... a successful track record in advancing novel technologies ... that includes the development of novel drugs and ...
Breaking Medicine Technology:VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4
... Patient Record Sharing , and Secure ... Among Physicians , DAYTON, Ohio, Oct. 29 ... (HSI) announce an effort to create virtual teams that connect primary ... care of patients, improving the quality and safety of care while ...
... IRVINE, Calif., Oct. 29 PRO-DEX, INC. (Nasdaq: PDEX ... quarter ending September 30, 2009. In addition, Pro-Dex announced ... renewed, a new marketing director has been hired, a product ... shipments have been made of a newly developed product. , ...
Cached Medicine Technology:Family Medicine Education Consortium, Inc. Endorses PatientCarenet.Org 2Family Medicine Education Consortium, Inc. Endorses PatientCarenet.Org 3Family Medicine Education Consortium, Inc. Endorses PatientCarenet.Org 4PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 2PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 3PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 4PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 5PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 6PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 7PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 8PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 9PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 10
... The IntraLase FS laser introduces new high ... Surgeons now have the opportunity to offer ... to a microkeratome for creating the corneal ... FS laser and proprietary IntraLASIK software, surgeons ...
... simple, effective screening test which is used to ... levels which are often a warning sign of ... which requires a single drop of blood obtained ... shown in clinical trials to be 94 to ...
The Lifestream Cholesterol Monitor provides you with a comprehensive tool to help you monitor your cholesterol as part of your wellness program. At a later date, you can purchase the other components...
... using patented, innovative technology, measures a complete ... only 5 minutes from a simple fingerstick. ... get immediate liver function results. The scope ... only advantage to healthcare providers. The physician, ...
Medicine Products: